Compound Interest: Evidence-Based Prioritization
Which compound should you target against which indication? Evidence-based prioritization can help you maximize potential profits.
See how >>
Commercial Leadership Interviews: Identifying Best Practices
A revealing glimpse into best practices from industry leaders, including how and when commercial strategy is being integrated into clinical and regulatory planning.
Read now >>
Evidence of Value: How to Build a Robust Argument
See how leading companies are using evidence reviews to guide early thinking on product value and differentiation, often avoiding the high costs of primary research.
Learn more >>
Nothing Costs More Than Failure: The Benefits of Early Commercial Strategy Development
As featured in a special edition of the Harvard Business Review.
See how your organization compares when it comes to the integration of commercial strategy into clinical and regulatory planning.